| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2013 | US8372860 Carboline derivatives useful in the inhibition of angiogenesis |
| 02/12/2013 | US8372859 CGRP receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups |
| 02/12/2013 | US8372858 Compounds and compositions as protein kinase inhibitors |
| 02/12/2013 | US8372857 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 02/12/2013 | US8372856 Hydrates of erlotinib hydrochloride |
| 02/12/2013 | US8372855 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
| 02/12/2013 | US8372854 Pyrrolo[2,3-D]pyrimidine compounds |
| 02/12/2013 | US8372852 Purines as reverse transcriptase inhibitors |
| 02/12/2013 | US8372851 Pyrazolo pyrimidines as casein kinase II (CK2) modulators |
| 02/12/2013 | US8372850 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 02/12/2013 | US8372848 N-benzylamino cyclic thioureas; obesity and related disorders; (N-(3-{(4S)-1-[(1S)-2-(benzylamino)-1-methylethyl]-3-[2-(3-fluorophenyl)ethyl]-2-thioxoimidazolidin-4-yl}propyl)guanidine |
| 02/12/2013 | US8372847 Pyrazinone modulator of corticotropin-releasing factor receptor activity |
| 02/12/2013 | US8372846 Co-crystals and pharmaceutical compositions comprising the same |
| 02/12/2013 | US8372845 Pyrazine derivatives as enac blockers |
| 02/12/2013 | US8372844 Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same |
| 02/12/2013 | US8372843 Quinolines useful as modulators of ION channels |
| 02/12/2013 | US8372842 Pyrazolopyridines as kinase inhibitors |
| 02/12/2013 | US8372841 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/12/2013 | US8372840 Potassium channel blockers |
| 02/12/2013 | US8372839 Bipartite inhibitors of bacterial RNA polymerase |
| 02/12/2013 | US8372838 Compounds as bradykinin B1 antagonists |
| 02/12/2013 | US8372837 Pyridone and pyridazone analogues as GPR119 modulators |
| 02/12/2013 | US8372836 Spray dried formulation |
| 02/12/2013 | US8372835 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 02/12/2013 | US8372834 Compositions and methods for delivery of anti-cancer agents |
| 02/12/2013 | US8372833 Urea derivative |
| 02/12/2013 | US8372832 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use |
| 02/12/2013 | US8372831 Isoxazoline linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof |
| 02/12/2013 | US8372830 Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival |
| 02/12/2013 | US8372829 Biocide composition comprising pyrithione and pyrrole derivatives |
| 02/12/2013 | US8372828 Therapeutic compositions |
| 02/12/2013 | US8372827 Therapeutic compositions |
| 02/12/2013 | US8372826 Estriol therapy for multiple sclerosis and other autoimmune diseases |
| 02/12/2013 | US8372825 Skin compositions containing hydrocortisone |
| 02/12/2013 | US8372824 GABA-steroid antagonists and their use for the treatment of CNS disorders |
| 02/12/2013 | US8372823 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 02/12/2013 | US8372822 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof |
| 02/12/2013 | US8372820 Composition comprising silicone oil or oils structured with compolymers carrying greater than 70% long chain alkyl group |
| 02/12/2013 | US8372818 Targeted double stranded RNA mediated cell killing |
| 02/12/2013 | US8372815 Use of lipid conjugates in the treatment of conjunctivitis |
| 02/12/2013 | US8372814 Ophthalmic formulations and uses thereof |
| 02/12/2013 | US8372813 Antibacterial aminoglycoside analogs |
| 02/12/2013 | US8372812 Phospholipid and protein tablets |
| 02/12/2013 | US8372808 Suppression of glial fibrillary acidic protein |
| 02/12/2013 | US8372807 Methods of modulating uric acid levels |
| 02/12/2013 | US8372800 Albumin-free factor VIII formulations |
| 02/12/2013 | US8372797 Treatment of erectile dysfunction by stem cell therapy |
| 02/12/2013 | US8372783 Permeable non-woven fabric based packaging for cut flowers |
| 02/12/2013 | US8372449 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering pruified quinic acid and/or carboxy alkyl ester |
| 02/12/2013 | US8372448 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester |
| 02/12/2013 | US8372431 Pharmaceutical composition comprising licarbazepine acetate |
| 02/12/2013 | US8372430 comprises stiffening agents for ameliorating side effects associated with adminstration of lipase inhibitors (anal leakage of undigested fat or oil); for treatment of diabetes |
| 02/12/2013 | US8372426 Dietary fiber composition |
| 02/12/2013 | US8372422 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers |
| 02/12/2013 | US8372420 Compositions and methods for coating medical implants |
| 02/12/2013 | US8372413 Mycobacterial disease, malaria, leishmaniasis, toxoplasmosis, schistosomiasis and clonorchiasis; antiallergens; asthma |
| 02/12/2013 | US8372402 Mammalian receptor proteins DCRS5; methods of treatment |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | US8372397 Methods for regulation of stem cells |
| 02/12/2013 | US8372395 Nano-emulsion composition of coenzyme Q10 |
| 02/12/2013 | US8372387 Compositions and methods for the treatment of heart failure |
| 02/12/2013 | US8372386 Keratotic plug removing composition |
| 02/12/2013 | US8372384 Quaternary ammonium functionalized cross-linked polyalkylsiloxanes with anti-fouling activity |
| 02/12/2013 | US8372032 Telescoping perfusion management system |
| 02/12/2013 | US8371292 Use of ciclesonide for the treatment of respiratory diseases |
| 02/12/2013 | CA2708502C Perhydroquinoxaline derivatives |
| 02/12/2013 | CA2707105C Inhibitors of stearoyl-coa desaturase |
| 02/12/2013 | CA2705163C Therapeutic uses of compounds having combined sert, 5-ht3 and 5-ht1a activity |
| 02/12/2013 | CA2701768C Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 02/12/2013 | CA2696705C New benzothiadiazepine derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 02/12/2013 | CA2694238C Pharmaceutical aerosol compositions comprising fluticasone |
| 02/12/2013 | CA2670313C Polymorphic forms of deferasirox (icl670a) |
| 02/12/2013 | CA2636275C Tetralone-based monoamine reuptake inhibitors |
| 02/12/2013 | CA2628750C 4-oxadiazolyl-piperidine compounds and use thereof |
| 02/12/2013 | CA2607441C Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/12/2013 | CA2601222C Once-a-day oxycodone formulations |
| 02/12/2013 | CA2596527C Igf-1r inhibitors |
| 02/12/2013 | CA2588401C 17,20(z)-dehydro vitamin d analogs and their uses |
| 02/12/2013 | CA2583920C Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 02/12/2013 | CA2580652C Compositions having body fat reducing function and food and drink containing the same |
| 02/12/2013 | CA2580577C Amitraz compositions |
| 02/12/2013 | CA2576257C Anti-inflammatory agents |
| 02/12/2013 | CA2574623C Acidic solid oral compositions without erosive potential in saliva and method for determining erosive potential in saliva |
| 02/12/2013 | CA2574464C Substituted quinolones |
| 02/12/2013 | CA2571587C Quaternary salt ccr2 antagonists |
| 02/12/2013 | CA2570155C 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases |
| 02/12/2013 | CA2566873C Use of drug combinations for treating insulin resistance |
| 02/12/2013 | CA2557260C Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
| 02/12/2013 | CA2551119C Lipase inhibitor |
| 02/12/2013 | CA2546647C Antidiabetic compounds comprising benzofuran and benzothiophene derivatives |
| 02/12/2013 | CA2539842C Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 02/12/2013 | CA2530281C Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders |
| 02/12/2013 | CA2529817C Novel antibacterial agents |
| 02/12/2013 | CA2510813C Injectable pharmaceutical compositions comprising sodium diclofenac and .beta.-cyclodextrin |
| 02/12/2013 | CA2498936C Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 02/12/2013 | CA2492747C Medicaments containing vardenafil hydrochloride trihydrate |
| 02/12/2013 | CA2487908C Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 02/12/2013 | CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors |
| 02/12/2013 | CA2477350C Novel crystalline forms of the anti-cancer compound zd1839 |